Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Robert Friel

Jan 31, 2008
Premium
Newly appointed PerkinElmer CEO Robert Friel’s salary for 2008 will increase to $875,000, according to a document filed with the US Securities and Exchange Commission last week.
 
Last week, the company announced Friel had been appointed CEO effective Feb. 1, to succeed Greg Summe. During the summer, he was promoted to president of the company, in which he will remain, as well as COO, from president of the Life and Analytical Sciences division.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Vaccine Authorization

The UK has given emergency authorization for Pfizer and BioNTech's SARS-CoV-2 vaccine, the Associated Press reports.

Healthcare Workers, Nursing Home Residents First

A US advisory committee says healthcare workers and nursing home residents should be prioritized to receive a SARS-CoV-2 vaccine, according to the Financial Times.

Hackers Target Vaccine Makers

The Wall Street Journal reports North Korean hackers have targeted half a dozen companies developing SARS-CoV-2 vaccines.

Cell Studies on Months-Long SARS-CoV-2 Shedding, Spike Mutation, Ebola Infection Dynamics

In Cell this week: long-term SARS-CoV-2 shedding, examination of the effects of a coronavirus spike protein mutation, and more.

What's Popular?

In Proteomics & Protein Research

  1. NanoString Technologies Reveals New High-Resolution Spatial Omics Platform Due 2022

    Premium

  2. Newomics Closes $7.9M Series B Funding Round

  3. Mini Mass Spec Firm 908 Devices Files for IPO

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.